WAM
Westport Asset Management Portfolio holdings
AUM
$226M
This Quarter Return
+13.32%
1 Year Return
+19.15%
3 Year Return
+80.96%
5 Year Return
+130.06%
10 Year Return
–
AUM
$219M
AUM Growth
+$219M
(+8.6%)
Cap. Flow
+$3.92M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
60.73%
Holding
76
New
2
Increased
3
Reduced
1
Closed
–
Top Buys
| 1 |
Oracle
ORCL
|
$2.6M |
| 2 |
Lumentum
LITE
|
$594K |
| 3 |
Check Point Software Technologies
CHKP
|
$560K |
| 4 |
VMW
VMware, Inc
VMW
|
$301K |
| 5 |
Cognyte Software
CGNT
|
$278K |
Top Sells
| 1 |
Teradata
TDC
|
$405K |
Sector Composition
| 1 | Technology | 36.56% |
| 2 | Financials | 17.14% |
| 3 | Consumer Staples | 10.56% |
| 4 | Healthcare | 8.86% |
| 5 | Industrials | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DISCA
26
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $2.17M | 0.99% |
50,000
| – | – |
|
27
Rockwell Automation
ROK
$38.6B
| $2.12M | 0.97% |
8,000
| – | – |
|
28
CVS Health
CVS
$92.8B
| $2.09M | 0.95% |
27,792
| – | – |
|
29
FMC
FMC
$4.88B
| $1.99M | 0.91% |
18,000
| – | – |
|
30
Ryman Hospitality Properties
RHP
$6.22B
| $1.94M | 0.89% |
25,000
| – | – |
|
31
Texas Instruments
TXN
$184B
| $1.9M | 0.87% |
10,062
| – | – |
|
32
Republic Services
RSG
$73B
| $1.89M | 0.86% |
19,000
| – | – |
|
33
Norfolk Southern
NSC
$62.8B
| $1.61M | 0.74% |
6,000
| – | – |
|
34
Union Pacific
UNP
$133B
| $1.5M | 0.68% |
6,800
| – | – |
|
35
Amazon
AMZN
$2.44T
| $1.35M | 0.62% |
436
| – | – |
|
36
IBM
IBM
$227B
| $1.33M | 0.61% |
10,000
| – | – |
|
37
CACI
CACI
$10.6B
| $1.23M | 0.56% |
5,000
| – | – |
|
|
VMW
38
DELISTED
VMware, Inc
VMW
| $1.2M | 0.55% |
8,000
+2,000
| +33% | +$301K |
|
39
AT&T
T
$209B
| $1.14M | 0.52% |
37,663
| – | – |
|
40
Eagle Materials
EXP
$7.49B
| $1.08M | 0.49% |
8,000
| – | – |
|
41
Air Products & Chemicals
APD
$65.5B
| $928K | 0.42% |
3,300
| – | – |
|
|
COHR
42
DELISTED
Coherent Inc
COHR
| $885K | 0.4% |
3,500
| – | – |
|
|
43
Lumentum
LITE
$9.28B
| $868K | 0.4% |
9,500
+6,500
| +217% | +$594K |
|
44
Bio-Rad Laboratories Class A
BIO
$8.06B
| $857K | 0.39% |
1,500
| – | – |
|
45
Gilead Sciences
GILD
$140B
| $776K | 0.35% |
12,000
| – | – |
|
46
AstraZeneca
AZN
$248B
| $746K | 0.34% |
15,000
| – | – |
|
47
Xylem
XYL
$34.5B
| $631K | 0.29% |
6,000
| – | – |
|
48
Skechers
SKX
$9.48B
| $626K | 0.29% |
15,000
| – | – |
|
49
Nutrien
NTR
$28B
| $601K | 0.27% |
11,150
| – | – |
|
50
Abbott
ABT
$231B
| $599K | 0.27% |
5,000
| – | – |
|